Repeated intravenous thrombolysis shows non-significant trend toward better functional outcomes in recurrent acute ischemic stroke
Repeated Thrombolysis Shows Potential for Recent Stroke Patients
This meta-analysis of individual patient data examines repeated intravenous thrombolysis (RIVT) for patients with recurrent acute ischemic s…
New data suggests that patients with a second stroke within 90 days may still benefit from thrombolysis treatment.
Telestroke systems are consistently associated with higher thrombolysis utilization in patients with suspected stroke
Telestroke Systems Linked to Higher Thrombolysis Use in Stroke Cases
This narrative review examines the impact of telestroke systems on thrombolysis utilization, stroke mimics, and clinical decision-making. Th…
Using telestroke systems is linked to more frequent thrombolysis for stroke patients, though it does not necessarily mean doctors are loweri…
Intravenous thrombolysis improves functional outcomes in patients with acute ischemic stroke after 4.5 hours
Late treatment for stroke may improve recovery and outcomes
This meta-analysis evaluated the impact of intravenous thrombolysis on adults with acute ischemic stroke treated beyond the standard four ho…
Patients receiving clot-busting drugs later than usual after a stroke may see better physical results, despite a higher risk of brain bleedi…
Low ADAMTS13 activity linked to ischemic stroke in meta-analysis of 8,993 patients
Low blood protein linked to higher stroke risk
This meta-analysis of 8,993 patients found that lower ADAMTS13 activity is associated with ischemic stroke (SMD -1.12; 95%CI -1.20 to -1.03)…
People with ischemic stroke have lower levels of a key blood protein. Could this be a new risk marker?
Thrombolysis plus endovascular therapy for basilar artery occlusion: a trial protocol
New trial plans to test stroke treatments for basilar artery
This randomized controlled trial protocol will compare intravenous thrombolysis plus endovascular treatment versus direct endovascular treat…
A large multi-center trial in China aims to see if adding clot-busting drugs improves recovery for patients with a specific type of stroke.